Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study

Morten Schou; Finn Gustafsson; Lars Videbaek; John Dennis Markenvard; Hans Ulrik Ulriksen; Henrik Ryde; Jens C H Jensen; Tonny Nielsen; Anne Knudsen; Christian D Tuxen; Jens Handberg; Per J Sørensen; Geert Espersen; Søren Poul Lind Rasmussen; Niels Keller; Kenneth Egstrup; Jens Olav Nielsen; Jawdat Abdulla; Ole Nyvad; Jens Peter Toft; Per R Hildebrandt

Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study

Morten Schou
, Finn Gustafsson
, Lars Videbaek
, John Dennis Markenvard
, Hans Ulrik Ulriksen
, Henrik Ryde
, Jens C H Jensen
, Tonny Nielsen
, Anne Knudsen
, Christian D Tuxen
, Jens Handberg
, Per J Sørensen
, Geert Espersen
, Søren Poul Lind Rasmussen
, Niels Keller
, Kenneth Egstrup
, Jens Olav Nielsen
, Jawdat Abdulla
, Ole Nyvad
, Jens Peter Toft

Per R Hildebrandt

22 Citations (Scopus)

Abstract

Randomized clinical trials have shown that newly discharged and symptomatic patients with chronic heart failure (CHF) benefit from follow-up in a specialized heart failure clinic (HFC). Clinical stable and educated patients are usually discharged from the HFC when on optimal therapy. It is unknown if risk stratification using natriuretic peptides could identify patients who would benefit from longer-term follow-up. Furthermore, data on the use of natriuretic peptides for monitoring of stable patients with CHF are sparse.

Original language	English
Journal	American Heart Journal
Volume	156
Issue number	4
Pages (from-to)	649-55
Number of pages	7
ISSN	0002-8703
Publication status	Published - Oct 2008
Externally published	Yes

Keywords

Ambulatory Care
Ambulatory Care Facilities
Continuity of Patient Care
Denmark
Heart Failure
Humans
Monitoring, Physiologic
Multicenter Studies as Topic
Natriuretic Peptide, Brain
Peptide Fragments
Randomized Controlled Trials as Topic
Research Design

Cite this

Schou, M., Gustafsson, F., Videbaek, L., Markenvard, J. D., Ulriksen, H. U., Ryde, H., Jensen, J. C. H., Nielsen, T., Knudsen, A., Tuxen, C. D., Handberg, J., Sørensen, P. J., Espersen, G., Rasmussen, S. P. L., Keller, N., Egstrup, K., Nielsen, J. O., Abdulla, J., Nyvad, O., ... Hildebrandt, P. R. (2008). Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study. American Heart Journal, 156(4), 649-55.

Schou, M , Gustafsson, F, Videbaek, L, Markenvard, JD, Ulriksen, HU, Ryde, H, Jensen, JCH, Nielsen, T, Knudsen, A, Tuxen, CD , Handberg, J, Sørensen, PJ, Espersen, G, Rasmussen, SPL, Keller, N, Egstrup, K, Nielsen, JO, Abdulla, J, Nyvad, O, Toft, JP & Hildebrandt, PR 2008, 'Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study', American Heart Journal, vol. 156, no. 4, pp. 649-55.

@article{1e602c7ec3494360a5183df15e7329a4,

title = "Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study",

abstract = "Randomized clinical trials have shown that newly discharged and symptomatic patients with chronic heart failure (CHF) benefit from follow-up in a specialized heart failure clinic (HFC). Clinical stable and educated patients are usually discharged from the HFC when on optimal therapy. It is unknown if risk stratification using natriuretic peptides could identify patients who would benefit from longer-term follow-up. Furthermore, data on the use of natriuretic peptides for monitoring of stable patients with CHF are sparse.",

keywords = "Ambulatory Care, Ambulatory Care Facilities, Continuity of Patient Care, Denmark, Heart Failure, Humans, Monitoring, Physiologic, Multicenter Studies as Topic, Natriuretic Peptide, Brain, Peptide Fragments, Randomized Controlled Trials as Topic, Research Design",

author = "Morten Schou and Finn Gustafsson and Lars Videbaek and Markenvard, \{John Dennis\} and Ulriksen, \{Hans Ulrik\} and Henrik Ryde and Jensen, \{Jens C H\} and Tonny Nielsen and Anne Knudsen and Tuxen, \{Christian D\} and Jens Handberg and S{\o}rensen, \{Per J\} and Geert Espersen and Rasmussen, \{S{\o}ren Poul Lind\} and Niels Keller and Kenneth Egstrup and Nielsen, \{Jens Olav\} and Jawdat Abdulla and Ole Nyvad and Toft, \{Jens Peter\} and Hildebrandt, \{Per R\}",

year = "2008",

month = oct,

language = "English",

volume = "156",

pages = "649--55",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Design and methodology of the NorthStar Study

T2 - NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study

AU - Schou, Morten

AU - Gustafsson, Finn

AU - Videbaek, Lars

AU - Markenvard, John Dennis

AU - Ulriksen, Hans Ulrik

AU - Ryde, Henrik

AU - Jensen, Jens C H

AU - Nielsen, Tonny

AU - Knudsen, Anne

AU - Tuxen, Christian D

AU - Handberg, Jens

AU - Sørensen, Per J

AU - Espersen, Geert

AU - Rasmussen, Søren Poul Lind

AU - Keller, Niels

AU - Egstrup, Kenneth

AU - Nielsen, Jens Olav

AU - Abdulla, Jawdat

AU - Nyvad, Ole

AU - Toft, Jens Peter

AU - Hildebrandt, Per R

PY - 2008/10

Y1 - 2008/10

N2 - Randomized clinical trials have shown that newly discharged and symptomatic patients with chronic heart failure (CHF) benefit from follow-up in a specialized heart failure clinic (HFC). Clinical stable and educated patients are usually discharged from the HFC when on optimal therapy. It is unknown if risk stratification using natriuretic peptides could identify patients who would benefit from longer-term follow-up. Furthermore, data on the use of natriuretic peptides for monitoring of stable patients with CHF are sparse.

AB - Randomized clinical trials have shown that newly discharged and symptomatic patients with chronic heart failure (CHF) benefit from follow-up in a specialized heart failure clinic (HFC). Clinical stable and educated patients are usually discharged from the HFC when on optimal therapy. It is unknown if risk stratification using natriuretic peptides could identify patients who would benefit from longer-term follow-up. Furthermore, data on the use of natriuretic peptides for monitoring of stable patients with CHF are sparse.

KW - Ambulatory Care

KW - Ambulatory Care Facilities

KW - Continuity of Patient Care

KW - Denmark

KW - Heart Failure

KW - Humans

KW - Monitoring, Physiologic

KW - Multicenter Studies as Topic

KW - Natriuretic Peptide, Brain

KW - Peptide Fragments

KW - Randomized Controlled Trials as Topic

KW - Research Design

M3 - Journal article

C2 - 18946891

SN - 0002-8703

VL - 156

SP - 649

EP - 655

JO - American Heart Journal

JF - American Heart Journal

IS - 4

ER -

Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study

Abstract

Keywords

Fingerprint

Cite this